• Kryptowährungen
  • Prognosemärkte
  • Nachrichten
  • Agentic Trading
  • Artikel
  • Ligen

Suche Kryptowährungen

Trendende Kryptowährungen

CoinRithm

Firma

Rechtsträger
Bees-x Limited
Unternehmensnummer
13308136
Eingetragen in
England and Wales
Eingetragener Sitz
Monmouth House, High Street, Watford, England, WD17 1LN

CoinRithm ist ein Informations- und Recherchedienst der Bees-x Limited. Das Unternehmen ist von der Financial Conduct Authority (FCA) nicht zur Ausübung regulierter Tätigkeiten zugelassen, und nichts auf dieser Website stellt Finanzberatung dar.

Entdecken

KryptowährungenPrognosemärkteNachrichtenArtikelAgent ArenaLigen

Funktionen

DashboardProbespielAgentic TradingPortfolioBeobachtungslisteEinstellungen

Firma

Über UnsMethodikNutzungsbedingungenDatenschutzrichtlinieCookie-RichtlinieHaftungsausschluss

Support

KundendienstFAQEntwickler-KitMCP-Dokumentation

Soziale Medien

X (Twitter)FacebookLinkedInTelegramInstagramTikTokYouTube
© 2026 CoinRithm. Alle Rechte vorbehalten.
Jetzt bei Google PlayLaden im App Store
  • Start
  • MärktePrognosemärkte
  • Nachrichten
  • Dashboard
  1. Prognosemärkte
  2. Health & Medicine
  3. When will Compass Pathways submit a NDA for COMP360 psilocybin?
When will Compass Pathways submit a NDA for COMP360 psilocybin?

When will Compass Pathways submit a NDA for COMP360 psilocybin?

1.0% (24h)Health & MedicineOne-OffWissenschaftBusiness & Corporate2Mon
KalshiKalshiVerfügbarkeit prüfenKYC erforderlich2% Gebühr
Aktuelle implizite Wahrscheinlichkeit
before September
before September 31%+1.0%
Führend unter 6 Optionen
Marktqualitat

28 / 100

Niedrige Qualität
24h-Volumen

0,3 €

Liquidität

38,2 €

Niedrige Liquidität
Geld / Brief

22.0% / 31.0%

Spread

40.9%

Breiter Spread
Marktdaten

Aktualisiert vor 3 Minuten

24. März 26, 14:001. Sept. 26, 14:00

Trends

Ergebnis24hWahrscheinlichkeit

Gewähltes Ergebnis

before September31%

Regeln

If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Sep 1, 2026, then the market resolves to Yes.

Kalshi
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Oct 1, 2026, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Nov 1, 2026, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Dec 1, 2026, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Jan 1, 2027, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Apr 1, 2027, then the market resolves to Yes.

Verwandte Märkte

When will Beam Therapeutics submit a BLA for Risto-cel?

When will Beam Therapeutics submit a BLA for Risto-cel?

0,3 €
before April 2027: 72%KalshiKALSHI
Will there be a year without polio before 2030?

Will there be a year without polio before 2030?

0 €
Ja: 10%KalshiKALSHI
When will Intellia Therapeutics submit a BLA for Lonvo-z?

When will Intellia Therapeutics submit a BLA for Lonvo-z?

0 €
before September: 45%KalshiKALSHI
Which countries will have an Ebola case in 2026?

Which countries will have an Ebola case in 2026?

108,8 €
Uganda: 100%PolymarketPOLYMARKET
US fertility rate up in Q1 2026?

US fertility rate up in Q1 2026?

0 €
Ja: 36%PolymarketPOLYMARKET
Which geographical areas will Tomorrow Bio cover at the end of 2026?

Which geographical areas will Tomorrow Bio cover at the end of 2026?

1059,7 €
🇨🇦 Canada: 23.9%Manifold MarketsMANIFOLD MARKETS

In diesen Themen aktiv

BitcoinBTC$62,682.54+2.38%EthereumETH$1,651.16+1.73%SolanaSOL$65.16+1.80%DogecoinDOGE$0.0851+1.95%XRPXRP$1.12+0.49%BNBBNB$595.34+1.77%

Verwandte Nachrichten

JPMorgan plans longer-running AI agents for corporate workflows Crypto NewsA16z, Paradigm lead $175 million bet to move global credit markets onchainCoindeskMorpho raises $175M at $2B valuation for institutional DeFi pushCrypto NewsAmazon signs Corning fiber deal to expand U.S. data centersCrypto NewsSpaceX Price Prediction: Will IPO Hype Justify a Multi-Trillion Dollar Valuation?Blockchain ReporterA massive hiring wave reveals trading firms are no longer viewing Polymarket as a niche betting toolCoindesk

Regeln

If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Sep 1, 2026, then the market resolves to Yes.

Kalshi
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Oct 1, 2026, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Nov 1, 2026, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Dec 1, 2026, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Jan 1, 2027, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Apr 1, 2027, then the market resolves to Yes.